Blood type frequencies in acute leukemia patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial studies whether certain blood types are more common in people with acute leukemia. It looks at your ABO and Rh blood type to see if there is a link, which might help doctors understand the disease better. If you have been diagnosed with acute leukemia recently, your medical records and blood type will be reviewed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute leukemia (either ALL or AML) for the first time.
- Your diagnosis was made between 2022 and 2025.
- Your blood type (ABO and Rh) is already known from your medical records.
- You are being treated at or referred to South Egypt Cancer Institute in Assiut University.
- You have not had a blood transfusion before your diagnosis or before your blood type was tested.
- You do not have any other cancers or chronic diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether the levels of certain proteins and blood clotting factors in your blood can help doctors understand acute myeloid leukemia better. It may lead to better ways to monitor the disease and its effects on your body.
This study looks at routine blood test results (called CBC) in people who have just been diagnosed with acute lymphoblastic leukemia (ALL), a type of blood cancer. The goal is to see if certain blood levels can help doctors understand the disease better and guide treatment.
This study looks at two simple blood tests in people newly diagnosed with ALL (a type of blood cancer) to see if these tests can help predict how the disease might progress. It may help doctors understand your condition better and could lead to more personalized care.
This study looks at how well a new scoring system predicts bleeding and clotting risks in people newly diagnosed with acute leukemia. By participating, you may help improve how doctors assess and manage these risks.
This study is looking at blood and bone marrow samples from people with acute leukemia to understand how the immune system reacts to the disease and treatment. The goal is to find better ways to treat leukemia.
This study looks at how often hospitalized patients with acute leukemia develop blood clots. By tracking this, doctors hope to learn who might be at higher risk and find better ways to prevent clots in the future.
Hear when a new Acute Leukemia (Including Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.